Widely varying estimates of treatment effects have been reported in randomized controlled trials (RCTs) investigating the efficacy of behavioural interventions for smoking cessation. Previous meta-analyses investigating behavioural interventions have important limitations and do not include recently published RCTs. We undertook a meta-analysis of RCTs to synthesize the treatment effects of four behavioural interventions, including minimal clinical intervention (brief advice from a healthcare worker), and intensive interventions, including individual, group, and telephone counselling.
Introduction
More than 50 million North-American adults are cigarette smokers. 1 Of these smokers, an estimated 19.2 million (43%) make at least one quit attempt of 24 h each year. 1 Behavioural interventions, defined as verbal instructions to modify healthrelated behaviours, are commonly used for smoking cessation.
Four commonly used behavioural interventions include minimal clinical intervention (brief advice from a healthcare worker) 2 and more intensive interventions, including individual counselling, group counselling, and telephone counselling. These four interventions have been extensively investigated in randomized controlled trials (RCTs), and these RCTs have produced widely varying quit rates.
Previous meta-analyses carried out by the Cochrane Collaboration 2 -6 and the Agency for Healthcare Research and Quality (AHRQ) 7 have concluded that all four behavioural interventions are efficacious at helping smokers quit. However, these meta-analyses included RCTs in which reports of smoking abstinence were not biochemically validated. They also included RCTs in which smoking abstinence was reported at varying follow-up times. Furthermore, 10 RCTs have recently been published that were not included in these previous meta-analyses. Consequently, there is a need to conduct a meta-analysis that includes only the most rigorous RCTs, in which reports of smoking abstinence were biochemically validated at specific follow-up times. In this meta-analysis, we combined the results from individual RCTs that reported biochemically validated abstinence using a hierarchical Bayesian random-effects 8 analysis to obtain estimates of the efficacy of smoking cessation behavioural interventions. Our objective was to determine how our meta-analysis, which only includes studies of the highest quality, compares with the previous Cochrane and AHRQ meta-analyses.
Methods

Search strategy
Randomized controlled trials of minimal clinical intervention, individual, group, and telephone counselling published in English were identified through a systematic search of the CDC Tobacco Information and Prevention, Cochrane Library, EMBASE, Medline, and PsycINFO databases. Several searches were carried out, each combining the term 'smoking' with the following key words: cognitive therapy, counselling, behavioural therapy, dentist, general practitioner, group counselling, group therapy, individual counselling, nurse, physician, and telephone counselling. The search was limited to RCTs published prior to August 2007. References from published RCTs, relevant reviews, and previous meta-analyses were examined for additional RCTs not identified in the database search. We classified RCTs according to the definitions for smoking cessation behavioural interventions provided by the Cochrane Collaboration. 2 Minimal clinical intervention was defined as brief advice to 'stop smoking' delivered in ,20 min by a healthcare worker during a single consultation. This advice included routine counselling, discussions, or recommendations that physicians or nurses (not trained in smoking cessation) provide their patients on a daily basis. Individual counselling was defined as one or more face-to-face encounters of 15 min or more between a smoker and a trained smoking cessation counsellor not involved in routine clinical care. Minimal clinical intervention is the treatment a patient may expect to receive upon a regular clinical visit. In contrast, individual counselling is the treatment a patient may expect to receive upon requesting aid from a trained smoking cessation therapist. Group counselling was defined as two or more behavioural therapy meetings in which at least two smokers were present. In group counselling sessions, smokers received advice from counsellors and were encouraged to discuss their problems with the group. Telephone counselling was defined as the provision of telephone calls to aid in smoking cessation. Calls were made to outpatients or to smokers recruited through a telephone helpline. We included RCTs investigating both pro-active telephone counselling (counsellor initiates calls) and reactive telephone counselling (counsellor responds to calls from smokers).
Included RCTs evaluated one of the four behavioural interventions combined with usual care, where usual care was administered to both the treatment and control arms. In RCTs investigating minimal clinical intervention, usual care consisted of only self-help materials or no treatment. In RCTs investigating individual, group, or telephone counselling, usual care was defined as brief advice from a healthcare worker to stop smoking with or without self-help materials. We included two types of RCTs which investigated more than one intervention strategy: (a) factorial-designed RCTs and (b) RCTs with multiple arms per intervention. For factorial-designed RCTs, we treated these as two separate RCTs and compared treatment arms such that the only difference between arms was the behavioural intervention itself. For RCTs with multiple arms per intervention, we reused the control group in each comparison. We accounted for this reuse in our analysis, avoiding double counting of groups from trials with multiple arms, while using all available data. We also restricted our meta-analysis to RCTs that reported biochemically validated point-prevalence and continuous smoking abstinence at 6 or 12 months. Randomized controlled trials in which the follow-up was conducted within a 2 week window prior to or after 6 or 12 months following the quit date were considered to have satisfied this criterion. We excluded RCTs reporting outcomes that were not biochemically validated or that were recorded at any time period other than 6 or 12 months. Also, we included only RCTs that randomized individual patients, and we excluded cluster RCTs that randomized physicians, therapists, or centres rather than patients. Typically, the efficacies of an intervention in individuals within a cluster tend to be more similar than the efficacies in individuals from different clusters. 9 Consequently, cluster RCTs may introduce biases in study design that are difficult to adjust for and were thus excluded. Finally, RCTs were also excluded if they had a statement specifying that recruited patients 'were not motivated' to quit smoking. All other RCTs that did not have such a statement were considered for inclusion in our meta-analysis. Two reviewers independently extracted information for each RCT. This information included demographic and clinical characteristics of the study populations, length of intervention, and smoking abstinence outcomes. Disagreements were resolved by consensus or by a third reviewer.
Classification of outcomes
For our analysis, we included the 'most rigorous criterion' of abstinence reported for each RCT. 10 The most rigorous criterion uses the most conservative outcome reported in any given RCT. Starting from the most conservative outcome, the criteria of abstinence reported were (a) continuous abstinence at 12 months, (b) continuous abstinence at 6 months, (c) point prevalence at 12 months, and (d) point prevalence at 6 months. Continuous abstinence was defined as strictly no smoking from the initial target quit date until follow-up at 6 or 12 months. Point prevalence was defined as no smoking over a time period, usually 7 days, directly preceding follow-up. Outcomes reported in terms of repeated point prevalence (subjects who were abstinent for a period of time immediately before two or more followups) were classified as continuous abstinence. In order to determine the true efficacy of behavioural interventions, we included only RCTs that verified smoking abstinence outcomes by means of biochemical validation. Finally, we calculated abstinence outcomes according to an intention-to-treat analysis, where patients who were randomized but lost to follow-up were considered smokers. Only patients who had moved or died prior to follow-up were excluded from the analysis.
Behavioural interventions for smoking cessation: a meta-analysis
Quality assessment
We measured the quality, or internal validity, of each RCT using a modified Jadad quality assessment scale. 11 We scored trials out of a maximum of 3 points. A maximum of 2 points were awarded on the basis of the method of randomization, and a maximum of 1 point was awarded for a description of patient withdrawals and dropouts. We did not assess for blinding since RCTs involving behavioural interventions are open-label owing to the nature of the intervention. On the basis of our modified scale, a score of 1 out of 3 signifies that the report has a high probability of bias, whereas scores of 2 or 3 have a medium and low probability of bias, respectively.
Statistical analysis
For each of the four behavioural interventions, a separate meta-analysis was performed to estimate the mean effect across individual RCTs. The results from RCTs investigating more than one intervention were analysed alongside RCTs investigating a single intervention provided that the treatment and control groups only differed by the intervention of interest. Our model used data from each arm from each trial exactly once, avoiding double counting of groups from RCTs with multiple arms, while using all available data. A Bayesian hierarchical meta-analysis based on a random-effects model was employed to account for RCT-to-RCT variability, which could arise from differences in patients' characteristics, trial methodology, setting, and intensity of adjunct support. In a Bayesian hierarchical model, the probability of an event within each RCT is allowed to vary between intervention and control groups, and effects across RCTs are assumed to vary according to a common distribution. To model the between-RCT variability, the logarithms of the odds ratio (OR) of each outcome variable were assumed to follow a normal distribution. The mean of the normal distribution therefore represents the mean intervention effect in RCTs on a log(OR) scale, and variance represents the variability between RCTs. A meta-analysis based upon the above model was conducted for each of the four behavioural interventions. To specify our Bayesian hierarchical model, we first assumed that each arm of each study independently estimated the probability p ij of smoking cessation, where i indexed each study and j indexed the group ( j ¼ 0 for the control group and j ¼ 1 for the intervention group). The log (OR) for trial i was defined as log(
). The collection of log(OR)s across the different RCTs was assumed to follow a normal distribution with mean m and variance s 2 . As discussed earlier, m represents the overall mean effect across RCTs, and s 2 represents the RCT-to-RCT variation. We used diffuse prior distributions for m and s 2 , so that all parameter estimates were almost entirely determined by the observed data. In our modelling, we did not use any tests for heterogeneity, since these tests typically have very low power and since the null hypothesis that all ORs are identical from trial to trial is not a priori plausible. Furthermore, Bayesian models do not rely on an assumption of homogeneity. Our Bayesian hierarchical model estimates a between-study variance parameter, s 2 , which controls the degree of pooling between studies.
The final ORs and credible intervals (CrIs) automatically reflect the degree of heterogeneity of the ORs between studies. Forest plots were produced to display the ORs and 95% CrI for all smoking cessation outcomes examined in our meta-analysis. Analyses were conducted using Winbugs 1.4.1. In Winbugs, we ran 1000 burn-in iterations, followed by 20 000 iterations for inference. Convergence was checked by verifying the sample paths to ensure that no nodes became stuck. In addition, we constructed funnel plots to assess for the possible presence of publication bias. The plots were created using MIX software.
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Results
We identified a total of 50 RCTs ( Figure 1 ) including 64 comparisons that met our inclusion criteria ( Tables 1-4 counselling (8646 patients), 18 evaluated group counselling (3600 patients), and 12 evaluated telephone counselling (8225 patients).
A total of 11 RCTs included two or more comparisons investigating different intervention strategies that were included in the meta-analysis. The average quality assessment score of all 50 RCTs was 2.14 on a scale of 3, suggesting that most of the RCTs had medium-to-low probability of bias. Characteristics of recruited patients varied widely among RCTs (Tables 1-4) . A total of 22 RCTs evaluated behavioural interventions in healthy populations. The remaining 28 RCTs were evaluated in 'at-risk' populations, such as pregnant women or diabetic patients, and miscellaneous populations corresponding to various age, sex, socioeconomic, or ethnic groups. The mean number of cigarettes smoked per day (CPD) of the study population varied between 20 and 30, with few exceptions, for individual, group, and telephone counselling (Tables 2-4) . However, the highest mean CPD for RCTs investigating minimal clinical intervention was only 22 ( Table 1) .
The method of delivery and duration of each behavioural intervention also varied among RCTs. Among the nine comparisons evaluating minimal clinical intervention, the mean duration of sessions varied from 1 to 20 min ( Table 1) . The mean total duration of sessions for RCTs investigating individual counselling varied from 13.5 min to 10 h ( Table 2) . For group counselling, the mean total duration of sessions varied from 7.5 to 16 h ( Table 3) . For telephone counselling, the mean total duration of sessions varied from 3 to 60 min (Table 4) . Furthermore, the number of sessions delivered and the treatment span (time frame) in which the sessions were delivered varied for each intervention.
Efficacy of smoking cessation behavioural interventions
A separate meta-analysis was performed for each of the four behavioural interventions, where smoking abstinence was defined using the most rigorous criterion reported (Figures 2 -5 ). The point estimate for minimal clinical intervention (OR 1.50, 95% CrI 0.84-2.78) suggests that it is efficacious at promoting smoking abstinence. However, we cannot draw any strong conclusions about the efficacy of minimal clinical intervention since its CrI was wide and included 1.0. Intensive interventions, including individual counselling (OR 1.49, 95% CrI 1.08-2.07), group counselling (OR 1.76, 95% CrI 1.11-2.93), and telephone counselling (OR 1.58, 95% CrI 1.15 -2.29), all substantially increased smoking abstinence compared with control. The wide CrIs for all four interventions prevented the ranking of interventions through indirect comparisons (data not shown). The point estimates of all four interventions are similar, suggesting that the efficacies of the different interventions were similar.
Discussion
Our meta-analysis was designed to assess the efficacy of four behavioural interventions at increasing smoking abstinence. We included only the most rigorous RCTs, in which reports of smoking abstinence were biochemically validated at two specific follow-up times (6 and/or 12 months). Individual, group, and We identified only nine RCTs investigating minimal clinical intervention in which reports of smoking abstinence were biochemically validated. Furthermore, only three of these RCTs enrolled over 1000 patients. Had more RCTs with larger patient populations been included in our meta-analysis, the wide CrI for minimal clinical intervention would have been narrower and likely would have not included unity. A narrower CrI would have allowed us to conclude with certainty that minimal clinical intervention is efficacious. Therefore, we recommend that healthcare workers advise smokers to quit, especially since minimal clinical intervention requires fewer resources than more intensive interventions. In addition, we recommend that physicians refer their patients for individual, group, or telephone counselling. Although these more intensive interventions entail higher costs, our meta-analysis has shown that they are efficacious at helping smokers quit.
Behavioural interventions might be more efficacious when used in combination with pharmacological interventions as part of a smoking cessation strategy. We identified five RCTs in the literature that met our inclusion criteria and that investigated the use of behavioural interventions as an adjunct to a particular pharmacotherapy. 14 -18 However, the number of RCTs investigating more than one intervention was insufficient to conclude whether a smoking cessation strategy combining pharmacotherapy and behavioural intervention was more efficacious than a strategy with behavioural intervention alone. Furthermore, a smoking cessation strategy consisting of only behavioural interventions may be particularly useful to smokers who are reluctant to using smoking cessation pharmacotherapy. The efficacy of smoking cessation pharmacological interventions has been previously investigated. 19 However, the efficacy of a cessation strategy combining pharmacotherapy and behavioural interventions remains poorly understood.
Previous studies
Previous meta-analyses on smoking cessation behavioural interventions have been carried out by the Cochrane Collaboration and the AHRQ. We classified the behavioural interventions using the definitions provided by the Cochrane Collaboration. The definition for minimal clinical intervention included counselling that lasted a maximum of 20 min, which allowed us to include more RCTs than the definition provided by the AHRQ. The AHRQ defined minimal counselling as lasting ,3 min, and thus, was very limiting. 7 The use of the AHRQ definition would have reduced the number of RCTs included in our meta-analysis from nine to five RCTs. Unlike our meta-analysis, the Cochrane 2,4 and AHRQ 7 meta-analyses obtained narrow confidence intervals (CIs). These previous meta-analyses concluded with certainty that minimal clinical intervention was efficacious at increasing smoking abstinence In addition to an individual counselling arm, patients were randomized to a telephone counselling arm.
b All subjects were provided one individual counselling session, one telephone counselling session, and 21 mg nicotine patches.
c All subjects were provided 44 mg nicotine patches.
d All subjects were provided 22 mg nicotine patches.
e Active intervention consisted of three counselling sessions. All subjects were provided one individual counselling session and 21 mg nicotine patches.
f Active intervention consisted of 12 counselling sessions. All subjects were provided one group counselling session, three individual counselling sessions, and 21 mg nicotine patches.
g All subjects were provided one individual counselling session.
h In addition to individual counselling, patients were randomized to telephone counselling.
i All subjects were provided one group counselling session. compared with control. In contrast, we obtained wider CrIs for each intervention by including only RCTs in which reports of smoking abstinence were biochemically validated. The efficacies for minimal clinical intervention, individual, group, and telephone counselling obtained in previous Cochrane meta-analyses were similar to the efficacy that we obtained. 3, 5, 6 However, our CrI for minimal clinical intervention was wide and included unity; therefore, we cannot draw strong conclusion about its efficacy. The AHRQ concluded that an exposure response relationship of behavioural interventions exists. 7 More intensive interventions, such as individual counselling, were more efficacious than minimal clinical interventions. In contrast, our results suggest that there is minimal difference in efficacy between the four interventions since their point estimates are similar and their CrIs overlap. However, head-to-head RCTs comparing the different interventions would be needed to confirm that the four interventions are equally efficacious. Nevertheless, minimal clinical intervention is likely a low-cost alternative to more intensive behavioural interventions which require a great deal of resources.
A cost-effectiveness analysis would be needed to confirm the cost benefits of minimal clinical interventions. Our strict inclusion criteria limited our meta-analysis to RCTs of the highest quality, thereby maximizing the internal validity of our results but yielding wide CrI. We included only RCTs with follow-up of smoking abstinence at 6 and/or 12 months. Previous meta-analyses, however, included RCTs reporting smoking abstinence at various follow-up times. Most importantly, we restricted our meta-analysis to RCTs that biochemically validated reports of smoking abstinence. Self-reports of smoking abstinence are not always reliable and may overestimate the efficacy of smoking cessation interventions, such as minimal clinical intervention. 20 Patients in at-risk populations, such as pregnant smokers or smokers with cardiovascular disease, are typically more likely to give false reports of smoking abstinence owing to societal pressures. Furthermore, patients who are in frequent contact with their counsellors, such as those receiving individual or group counselling, may be more likely to give false reports of smoking abstinence owing to their desire to not disappoint their counsellors. Finally, we also maximized the internal validity of our results by using Bayesian models, which account for greater uncertainty and thus produce wider intervals. 8 
Limitations
Our meta-analysis has a number of potential limitations. First, the motivation of patients, the number of CPD, ethnicity, and age all contributed to the heterogeneity of RCTs. Randomized controlled trials also varied in the total duration of counselling sessions, the number of sessions, and the type of treatment provider (i.e. physician, nurse). We partially accounted for these variations by employing a random effects model for our meta-analysis. Furthermore, hierarchical Bayesian models do not rely on a homogeneity assumption. Second, the smoking abstinence outcomes also varied between RCTs; some reported the point prevalence of abstinence at 6 and/or 12 months, whereas others reported continuous abstinence at 6 and/or 12 months. We analysed the outcomes using the most rigorous criterion of smoking abstinence, as used previously. 10 Third, the smokers selected to participate in RCTs are typically more motivated than smokers in actual practice. Fourth, publication bias is a potential limitation for our meta-analysis as is true for virtually any meta-analysis. Fifth, we limited our search to RCTs published in English. However, ,5% of RCTs identified in our literature search were published in a language other than English. Finally, we may have underestimated the efficacy of intensive behavioural interventions. In RCTs examining intensive interventions, the control consisted of brief advice from a healthcare worker. Brief advice alone may improve smoking abstinence in the control, which would consequently lower the point estimate of the OR for intensive interventions.
Conclusion
The use of intensive behavioural interventions, including individual, group, and telephone counselling, results in substantial increases in smoking abstinence compared with control in smokers motivated to quit. Although minimal clinical intervention may increase smoking abstinence, there is insufficient evidence to draw strong conclusions regarding its efficacy. However, in addition to advising patients to quit smoking, we recommend that healthcare workers also advise smokers to seek more intensive individual, group, or telephone counselling for smoking cessation. The point estimates of efficacy for the four behavioural interventions are similar; however, in the absence of head-to-head RCTs, we are unable to confirm if all four interventions are equally efficacious.
Supplementary material
Supplementary material is available at European Heart Journal online. All subjects were provided one group counselling session and 22 mg nicotine patches. (6) Active intervention consisted of reactive and pro-active counselling. All subjects were provided one group counselling session and 22 mg nicotine patches. (7) In addition to a telephone counselling arm, patients were randomized to an individual counselling arm.
